Report Detail
Global Biological API Drug Manufacturing Sales Market Report 2021
- RnM4198463 |
- 16 June, 2021 |
- Global |
- 146 Pages |
- QYResearch |
- Chemical & Material
It is an API produced by human, animal, microbial, genetic engineering or changing its source and through fermentation, bacterial culture, biotechnology and subsequent purification processes.
Market Analysis and Insights: Global Biological API Drug Manufacturing Market
The global Biological API Drug Manufacturing market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.
Global Biological API Drug Manufacturing Scope and Market Size
The global Biological API Drug Manufacturing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biological API Drug Manufacturing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
In-House manufacturing
Contract manufacturing
API contract manufacturing dominates the global biological API drug manufacturing market.
Segment by Application
Monoclonal Antibody (mAb) Therapies
Vaccines
Insulin Therapies
Interferon Therapies
Other
The Biological API Drug Manufacturing market is analysed and market size information is provided by regions (countries). Segment by Application, the Biological API Drug Manufacturing market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Lonza
Boehringer Ingelheim BioXcellence
Celltrion
DSM
Samsung BioLogics
Fujifilm Diosynth Biotechnologies
Cytovance Biologics
AbbVie
Baxter
CEPiA Sanofi
GSK
Pfizer CentreOne
Sandoz
Vetter
Wuxi Biologics
1 Biological API Drug Manufacturing Market Overview
- 1.1 Biological API Drug Manufacturing Product Scope
- 1.2 Biological API Drug Manufacturing Segment by Type
- 1.2.1 Global Biological API Drug Manufacturing Sales by Type (2016 & 2021 & 2027)
- 1.2.2 In-House manufacturing
- 1.2.3 Contract manufacturing
- 1.3 Biological API Drug Manufacturing Segment by Application
- 1.3.1 Global Biological API Drug Manufacturing Sales Comparison by Application (2016 & 2021 & 2027)
- 1.3.2 Monoclonal Antibody (mAb) Therapies
- 1.3.3 Vaccines
- 1.3.4 Insulin Therapies
- 1.3.5 Interferon Therapies
- 1.3.6 Other
- 1.4 Biological API Drug Manufacturing Market Estimates and Forecasts (2016-2027)
- 1.4.1 Global Biological API Drug Manufacturing Market Size in Value Growth Rate (2016-2027)
- 1.4.2 Global Biological API Drug Manufacturing Market Size in Volume Growth Rate (2016-2027)
- 1.4.3 Global Biological API Drug Manufacturing Price Trends (2016-2027)
2 Biological API Drug Manufacturing Estimates and Forecasts by Region
- 2.1 Global Biological API Drug Manufacturing Market Size by Region: 2016 VS 2021 VS 2027
- 2.2 Global Biological API Drug Manufacturing Retrospective Market Scenario by Region (2016-2021)
- 2.2.1 Global Biological API Drug Manufacturing Sales Market Share by Region (2016-2021)
- 2.2.2 Global Biological API Drug Manufacturing Revenue Market Share by Region (2016-2021)
- 2.3 Global Biological API Drug Manufacturing Market Estimates and Forecasts by Region (2022-2027)
- 2.3.1 Global Biological API Drug Manufacturing Sales Estimates and Forecasts by Region (2022-2027)
- 2.3.2 Global Biological API Drug Manufacturing Revenue Forecast by Region (2022-2027)
- 2.4 Geographic Market Analysis: Market Facts & Figures
- 2.4.1 North America Biological API Drug Manufacturing Estimates and Projections (2016-2027)
- 2.4.2 Europe Biological API Drug Manufacturing Estimates and Projections (2016-2027)
- 2.4.3 China Biological API Drug Manufacturing Estimates and Projections (2016-2027)
- 2.4.4 Japan Biological API Drug Manufacturing Estimates and Projections (2016-2027)
- 2.4.5 Southeast Asia Biological API Drug Manufacturing Estimates and Projections (2016-2027)
- 2.4.6 India Biological API Drug Manufacturing Estimates and Projections (2016-2027)
3 Global Biological API Drug Manufacturing Competition Landscape by Players
- 3.1 Global Top Biological API Drug Manufacturing Players by Sales (2016-2021)
- 3.2 Global Top Biological API Drug Manufacturing Players by Revenue (2016-2021)
- 3.3 Global Biological API Drug Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biological API Drug Manufacturing as of 2020)
- 3.4 Global Biological API Drug Manufacturing Average Price by Company (2016-2021)
- 3.5 Manufacturers Biological API Drug Manufacturing Manufacturing Sites, Area Served, Product Type
- 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Biological API Drug Manufacturing Market Size by Type
- 4.1 Global Biological API Drug Manufacturing Historic Market Review by Type (2016-2021)
- 4.1.1 Global Biological API Drug Manufacturing Sales Market Share by Type (2016-2021)
- 4.1.2 Global Biological API Drug Manufacturing Revenue Market Share by Type (2016-2021)
- 4.1.3 Global Biological API Drug Manufacturing Price by Type (2016-2021)
- 4.2 Global Biological API Drug Manufacturing Market Estimates and Forecasts by Type (2022-2027)
- 4.2.1 Global Biological API Drug Manufacturing Sales Forecast by Type (2022-2027)
- 4.2.2 Global Biological API Drug Manufacturing Revenue Forecast by Type (2022-2027)
- 4.2.3 Global Biological API Drug Manufacturing Price Forecast by Type (2022-2027)
5 Global Biological API Drug Manufacturing Market Size by Application
- 5.1 Global Biological API Drug Manufacturing Historic Market Review by Application (2016-2021)
- 5.1.1 Global Biological API Drug Manufacturing Sales Market Share by Application (2016-2021)
- 5.1.2 Global Biological API Drug Manufacturing Revenue Market Share by Application (2016-2021)
- 5.1.3 Global Biological API Drug Manufacturing Price by Application (2016-2021)
- 5.2 Global Biological API Drug Manufacturing Market Estimates and Forecasts by Application (2022-2027)
- 5.2.1 Global Biological API Drug Manufacturing Sales Forecast by Application (2022-2027)
- 5.2.2 Global Biological API Drug Manufacturing Revenue Forecast by Application (2022-2027)
- 5.2.3 Global Biological API Drug Manufacturing Price Forecast by Application (2022-2027)
6 North America Biological API Drug Manufacturing Market Facts & Figures
- 6.1 North America Biological API Drug Manufacturing Sales by Company
- 6.1.1 North America Biological API Drug Manufacturing Sales by Company (2016-2021)
- 6.1.2 North America Biological API Drug Manufacturing Revenue by Company (2016-2021)
- 6.2 North America Biological API Drug Manufacturing Sales Breakdown by Type
- 6.2.1 North America Biological API Drug Manufacturing Sales Breakdown by Type (2016-2021)
- 6.2.2 North America Biological API Drug Manufacturing Sales Breakdown by Type (2022-2027)
- 6.3 North America Biological API Drug Manufacturing Sales Breakdown by Application
- 6.3.1 North America Biological API Drug Manufacturing Sales Breakdown by Application (2016-2021)
- 6.3.2 North America Biological API Drug Manufacturing Sales Breakdown by Application (2022-2027)
7 Europe Biological API Drug Manufacturing Market Facts & Figures
- 7.1 Europe Biological API Drug Manufacturing Sales by Company
- 7.1.1 Europe Biological API Drug Manufacturing Sales by Company (2016-2021)
- 7.1.2 Europe Biological API Drug Manufacturing Revenue by Company (2016-2021)
- 7.2 Europe Biological API Drug Manufacturing Sales Breakdown by Type
- 7.2.1 Europe Biological API Drug Manufacturing Sales Breakdown by Type (2016-2021)
- 7.2.2 Europe Biological API Drug Manufacturing Sales Breakdown by Type (2022-2027)
- 7.3 Europe Biological API Drug Manufacturing Sales Breakdown by Application
- 7.3.1 Europe 146 Sales Breakdown by Application (2016-2021)
- 7.3.2 Europe 146 Sales Breakdown by Application (2022-2027)
8 China Biological API Drug Manufacturing Market Facts & Figures
- 8.1 China Biological API Drug Manufacturing Sales by Company
- 8.1.1 China Biological API Drug Manufacturing Sales by Company (2016-2021)
- 8.1.2 China Biological API Drug Manufacturing Revenue by Company (2016-2021)
- 8.2 China Biological API Drug Manufacturing Sales Breakdown by Type
- 8.2.1 China Biological API Drug Manufacturing Sales Breakdown by Type (2016-2021)
- 8.2.2 China Biological API Drug Manufacturing Sales Breakdown by Type (2022-2027)
- 8.3 China Biological API Drug Manufacturing Sales Breakdown by Application
- 8.3.1 China 314 Sales Breakdown by Application (2016-2021)
- 8.3.2 China 314 Sales Breakdown by Application (2022-2027)
9 Japan Biological API Drug Manufacturing Market Facts & Figures
- 9.1 Japan Biological API Drug Manufacturing Sales by Company
- 9.1.1 Japan Biological API Drug Manufacturing Sales by Company (2016-2021)
- 9.1.2 Japan Biological API Drug Manufacturing Revenue by Company (2016-2021)
- 9.2 Japan Biological API Drug Manufacturing Sales Breakdown by Type
- 9.2.1 Japan Biological API Drug Manufacturing Sales Breakdown by Type (2016-2021)
- 9.2.2 Japan Biological API Drug Manufacturing Sales Breakdown by Type (2022-2027)
- 9.3 Japan Biological API Drug Manufacturing Sales Breakdown by Application
- 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
- 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Biological API Drug Manufacturing Market Facts & Figures
- 10.1 Southeast Asia Biological API Drug Manufacturing Sales by Company
- 10.1.1 Southeast Asia Biological API Drug Manufacturing Sales by Company (2016-2021)
- 10.1.2 Southeast Asia Biological API Drug Manufacturing Revenue by Company (2016-2021)
- 10.2 Southeast Asia Biological API Drug Manufacturing Sales Breakdown by Type
- 10.2.1 Southeast Asia Biological API Drug Manufacturing Sales Breakdown by Type (2016-2021)
- 10.2.2 Southeast Asia Biological API Drug Manufacturing Sales Breakdown by Type (2022-2027)
- 10.3 Southeast Asia Biological API Drug Manufacturing Sales Breakdown by Application
- 10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
- 10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)
11 India Biological API Drug Manufacturing Market Facts & Figures
- 11.1 India Biological API Drug Manufacturing Sales by Company
- 11.1.1 India Biological API Drug Manufacturing Sales by Company (2016-2021)
- 11.1.2 India Biological API Drug Manufacturing Revenue by Company (2016-2021)
- 11.2 India Biological API Drug Manufacturing Sales Breakdown by Type
- 11.2.1 India Biological API Drug Manufacturing Sales Breakdown by Type (2016-2021)
- 11.2.2 India Biological API Drug Manufacturing Sales Breakdown by Type (2022-2027)
- 11.3 India Biological API Drug Manufacturing Sales Breakdown by Application
- 11.3.1 India Biological API Drug Manufacturing Sales Breakdown by Application (2016-2021)
- 11.3.2 India Biological API Drug Manufacturing Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Biological API Drug Manufacturing Business
- 12.1 Lonza
- 12.1.1 Lonza Corporation Information
- 12.1.2 Lonza Business Overview
- 12.1.3 Lonza Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
- 12.1.4 Lonza Biological API Drug Manufacturing Products Offered
- 12.1.5 Lonza Recent Development
- 12.2 Boehringer Ingelheim BioXcellence
- 12.2.1 Boehringer Ingelheim BioXcellence Corporation Information
- 12.2.2 Boehringer Ingelheim BioXcellence Business Overview
- 12.2.3 Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
- 12.2.4 Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Products Offered
- 12.2.5 Boehringer Ingelheim BioXcellence Recent Development
- 12.3 Celltrion
- 12.3.1 Celltrion Corporation Information
- 12.3.2 Celltrion Business Overview
- 12.3.3 Celltrion Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
- 12.3.4 Celltrion Biological API Drug Manufacturing Products Offered
- 12.3.5 Celltrion Recent Development
- 12.4 DSM
- 12.4.1 DSM Corporation Information
- 12.4.2 DSM Business Overview
- 12.4.3 DSM Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
- 12.4.4 DSM Biological API Drug Manufacturing Products Offered
- 12.4.5 DSM Recent Development
- 12.5 Samsung BioLogics
- 12.5.1 Samsung BioLogics Corporation Information
- 12.5.2 Samsung BioLogics Business Overview
- 12.5.3 Samsung BioLogics Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
- 12.5.4 Samsung BioLogics Biological API Drug Manufacturing Products Offered
- 12.5.5 Samsung BioLogics Recent Development
- 12.6 Fujifilm Diosynth Biotechnologies
- 12.6.1 Fujifilm Diosynth Biotechnologies Corporation Information
- 12.6.2 Fujifilm Diosynth Biotechnologies Business Overview
- 12.6.3 Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
- 12.6.4 Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Products Offered
- 12.6.5 Fujifilm Diosynth Biotechnologies Recent Development
- 12.7 Cytovance Biologics
- 12.7.1 Cytovance Biologics Corporation Information
- 12.7.2 Cytovance Biologics Business Overview
- 12.7.3 Cytovance Biologics Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
- 12.7.4 Cytovance Biologics Biological API Drug Manufacturing Products Offered
- 12.7.5 Cytovance Biologics Recent Development
- 12.8 AbbVie
- 12.8.1 AbbVie Corporation Information
- 12.8.2 AbbVie Business Overview
- 12.8.3 AbbVie Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
- 12.8.4 AbbVie Biological API Drug Manufacturing Products Offered
- 12.8.5 AbbVie Recent Development
- 12.9 Baxter
- 12.9.1 Baxter Corporation Information
- 12.9.2 Baxter Business Overview
- 12.9.3 Baxter Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
- 12.9.4 Baxter Biological API Drug Manufacturing Products Offered
- 12.9.5 Baxter Recent Development
- 12.10 CEPiA Sanofi
- 12.10.1 CEPiA Sanofi Corporation Information
- 12.10.2 CEPiA Sanofi Business Overview
- 12.10.3 CEPiA Sanofi Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
- 12.10.4 CEPiA Sanofi Biological API Drug Manufacturing Products Offered
- 12.10.5 CEPiA Sanofi Recent Development
- 12.11 GSK
- 12.11.1 GSK Corporation Information
- 12.11.2 GSK Business Overview
- 12.11.3 GSK Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
- 12.11.4 GSK Biological API Drug Manufacturing Products Offered
- 12.11.5 GSK Recent Development
- 12.12 Pfizer CentreOne
- 12.12.1 Pfizer CentreOne Corporation Information
- 12.12.2 Pfizer CentreOne Business Overview
- 12.12.3 Pfizer CentreOne Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
- 12.12.4 Pfizer CentreOne Biological API Drug Manufacturing Products Offered
- 12.12.5 Pfizer CentreOne Recent Development
- 12.13 Sandoz
- 12.13.1 Sandoz Corporation Information
- 12.13.2 Sandoz Business Overview
- 12.13.3 Sandoz Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
- 12.13.4 Sandoz Biological API Drug Manufacturing Products Offered
- 12.13.5 Sandoz Recent Development
- 12.14 Vetter
- 12.14.1 Vetter Corporation Information
- 12.14.2 Vetter Business Overview
- 12.14.3 Vetter Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
- 12.14.4 Vetter Biological API Drug Manufacturing Products Offered
- 12.14.5 Vetter Recent Development
- 12.15 Wuxi Biologics
- 12.15.1 Wuxi Biologics Corporation Information
- 12.15.2 Wuxi Biologics Business Overview
- 12.15.3 Wuxi Biologics Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
- 12.15.4 Wuxi Biologics Biological API Drug Manufacturing Products Offered
- 12.15.5 Wuxi Biologics Recent Development
13 Biological API Drug Manufacturing Manufacturing Cost Analysis
- 13.1 Biological API Drug Manufacturing Key Raw Materials Analysis
- 13.1.1 Key Raw Materials
- 13.1.2 Key Raw Materials Price Trend
- 13.1.3 Key Suppliers of Raw Materials
- 13.2 Proportion of Manufacturing Cost Structure
- 13.3 Manufacturing Process Analysis of Biological API Drug Manufacturing
- 13.4 Biological API Drug Manufacturing Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
- 14.1 Marketing Channel
- 14.2 Biological API Drug Manufacturing Distributors List
- 14.3 Biological API Drug Manufacturing Customers
15 Market Dynamics
- 15.1 Biological API Drug Manufacturing Market Trends
- 15.2 Biological API Drug Manufacturing Drivers
- 15.3 Biological API Drug Manufacturing Market Challenges
- 15.4 Biological API Drug Manufacturing Market Restraints
16 Research Findings and Conclusion
17 Appendix
- 17.1 Research Methodology
- 17.1.1 Methodology/Research Approach
- 17.1.2 Data Source
- 17.2 Author List
Summary:
Get latest Market Research Reports on Biological API Drug Manufacturing. Industry analysis & Market Report on Biological API Drug Manufacturing is a syndicated market report, published as Global Biological API Drug Manufacturing Sales Market Report 2021. It is complete Research Study and Industry Analysis of Biological API Drug Manufacturing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
